chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After about 5 minutes after receiving the vaccine, the husband of the patient came to the pharmacy to notify the pharmacist that the patient had fainted.  The pharmacist had technician call 911 and the pharmacist went to evaluate the patient.  Upon arrival, the patient had gained consciousness.  The pharmacist got a BP and HR.  Talked to patient until EMS arrived.  After talking with EMS, the patient left with the husband.
Patient experienced syncope approximately 5 minutes after receiving vaccine.  Patient fell from chair.  Patient came to immediately.  Patient was rolled over, placed flat on ground with legs elevated.  Was immediately examined by PA.  Blood pressures were taken approximately every 5 to 10 minutes over the next 30 to 45 minutes.  Average BP was 130/90 Pulse 81.  No significant visual injuries were noted.  Patient returned home unadded.  Follow up phone call was made the next morning, patient reported no significant issues and was feeling fine.
This spontaneous report as received from a registered pharmacist refers to a patient of unknown age who on 26-AUG-2013, was vaccinated with a dose of ZOSTAVAX (lot # 0168AE) (dose and route not reported) that was expired. The vaccine expired on 06-MAR-2013. No adverse effects were reported.  Additional information has been requested.
Age: 43 years 12/23/2020 12:21 Chief Complaint: ALLERGIC REACTION   History of Presenting Illness: This 43 yo female presents from specialty clinic for an allergic reaction. Patient has just received the Moderna Sars-Cov2 vaccine. She has had covid in the past, and her Igg tested outpatient was positive at 5.2 (per patient). She had received the vaccine at 11, and says that she usually has a reaction to vaccinations and drugs. She began having some rash around the neck and felt like her throat was closing. She was brought to the emergency room.
Client's mother called 4 hours after vaccine administration to state client was feeling fatigued, body aches, low grade fever with chills, back pain and numbness sensations in legs.
flu symptoms, chills, fever for  5 days, shallow breathing, left arm pain & swelling for 3 weeks pelvic pain, heart pain, red bumps on body
a patient tested positive for covid19 after getting a second dose of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (a patient tested positive for covid19 after getting a second dose of the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (a patient tested positive for covid19 after getting a second dose of the vaccine). At the time of the report, COVID-19 (a patient tested positive for covid19 after getting a second dose of the vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient came to Health Department  received a  Moderna Covid - 19 vaccine 1/11/2021 Lot # 025J20-2A Returned to Health Department  received a Johnson & Johnson Covid - 19 vaccine 05/28/2021 Lot # 203A21A
Patient is a 86 y.o. male with a history of Afib on eliquis, CAD, HLD, and HTN, tested positive for COVID-19 on 9/15/23 who presented to hospital 9/18/2023 with dyspnea and found to be hypotensive, COVID-19 positive. Admitted to the ICU and placed on vasopressor support. Course complicated by AKI, cardiogenic shock, and elevated LFTS with hep A. Medone was consulted to assume care upon transfer out of the ICU. Weaned to RA. Family and patient refused SNF. Discharged home    1. Acute Hypoxemic Respiratory Failure due to COVID-19: pneumonia. tested positive for COVID-19 on 9/15/23, CXR with bilateral effusions and right lower lobe infiltrate.s/p paxlovid  PTA. Required HHFNC, weaned to RA. S/p decadron while inpatient.  Not a candidate for Remdesivir given elevated LFTs. Continue airborne precautions until 9/25/2023.  Weaned to room air. 2. Mixed Cardiogenic and Septic Shock: TTE 9/19/23 showed EF ~30% with septal and anteroseptal hypokinesis. 9/18/23 blood cultures negative, S/p lasix and dobutamine drip. S/p zosyn and Rocephin.  Daughter requested Augmentin at discharge. 3. Acute on Chronic Systolic CHF: Echo 9/19/23 with EF 30%, overloaded on admit, BNP 4100, s/p lasix drip. Transitioned to home oral lasix 9/20/23,  4. Acute Renal Failure with hypkalemia: creat 3.64 on admit, baseline normal. Prerenal/ATN in setting of cardiogenic shock. Down-trended to creat 1.96 on 9/21/23.  Improved 5. Anion Gap Acidosis with metabolic acidosis with lactic acidosis: secondary to sepsis/AKI. Resolved  6. Elevated LFT's: On admit AST/ALT 1444/1268, AP 166. INR 2.2. multifactorial in setting of  shock liver, congestive hepatopathy  and possibly worsened in the setting of hepatitis A infection and Paxlovid use. Hep A IgM positive; Hep B core antigen and surface antibody negative. RUQ ultrasound unremarkable. 7. Paroxysmal Afib: hx PPM, continued eliquis.  Patient cannot  Continued home nifedipine and toprol 8. Steroid Induced Hyperglycemia: SSI added while on steroids, inpatient  . A1c and Blood sugar trend with PCP. Stopped steroids at dc 9. Acute Encephalopathy: suspect metabolic etiology, s/p precedex-weaned off.  Resolved  10. Elevated Troponin: troponin 50, secondary to demand ischemia. EKG without ischemic changes. 11. GERD: refused Protonix, reports relief with TUMS 12. Hep A: positive 9/20/23. Improved symptoms
Patient called the day after vaccines were administered complaining of fever, sweating, severe shaking, confusion and possibly passing out about 6 hours after receiving these vaccinations. All symptoms have resided today and the patient was instructed to call the pharmacy or to seek medical attention if these recur.
DENTURES MADE GAG AFTER RECEIVING VACCINE; This spontaneous report received from a patient concerned a 54 year old male. The patient's height, and weight were not reported. The patient's past medical history included spinal issues 7 surgeries,, and concurrent conditions included ex-smoker, non alcoholic, and non smoker, and other pre-existing medical conditions included the patient had no known allergies. the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and batch number: 1805020 expiry: 01/MAY/2021) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced dentures made gag after receiving vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dentures made gag after receiving vaccine. This report was non-serious.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/23/20 pfizer,Lot#e1040 2nd dose: 01/13/21Pfizer,Lot# E1040 Diagnosed covid positive:07/2821 Symptom onset:07/24/21 Exposure:Home Symptoms:Fatigue, loss of smell, taste.
Right arm edema, erythema, increased temp, chilling, frequent urination and joints aching and malaise.
rt arm 3_4" in diam erythema warm;no tenderness po & DTP booster;
This case was reported by a nurse and described the occurrence of localized erythema in a 72- year-old female patient who received SHINGRIX. On 2nd May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 5th May 2018, 3 days after receiving SHINGRIX, the patient experienced localized erythema, tenderness and skin warm. On an unknown date, the outcome of the localized erythema, tenderness and skin warm were unknown. It was unknown if the reporter considered the localized erythema, tenderness and skin warm to be related to SHINGRIX. Additional details were provided as follows: After receiving SHINGRIX, patient experienced patch of erythema with mild warmth and tenderness in the left mid arm of the 2 by 1.5 cm. Also, at lateral mid arm of the patient, 1 cm patch of erythema with mild warmth and tenderness was observed.
Information has been received from a registered nurse concerning a 7-year old white male with no allergies or medical history who on 08-Jan-1998 was vaccinated in the left thigh with a 0.5 mL first dose of varicella virus vaccine live (lot #624648/1323E). Concomitant therapy on the same day included a first dose in the right thigh of measles-mumps-rubella vaccine (lot #624115/1019E). There was no illness at the time of vaccination. On 14-Feb-2004 at 10:00 am, the patient started with a blistery rash. He also had a low-grade fever and sore throat. The rash was all over the body but was worse on the trunk and groin area. On 16-Feb-2004 a rapid strep test was done which was negative. A prescription drug was not required to treat the experience. Additional information has been requested. Follow up report: the patient recovered. No further inforrmation is expected.
Information has been received from a pharmacist who reported that a patient may have received a dose of expired PNEUMOVAX 23. The pharmacist declined to provide any additional information. No adverse effect reported. No other information is available at this time. Additional information is not expected.
patient had chest pain and SOB Day 2 after vaccine and in ER has signs of myocarditis requiring hospitalization
Sore arm for the first 2-3 days after the vaccine was given. No other symptoms are problems until February 19, 2021 (11 days after the vaccine was given). On this day I noticed a light pink rash (~2 inches in diameter), warmth, and firmness at the injection site. No other symptoms. This rash lasted only 1 day.
Musculoskeletal: area of maximal tenderness is over anterior shoulder, limited AROM Right shoulder especially in internal rotation and extension;  Discussed that no sign of bacterial infection, most likely multifactorial, involving swelling of lymph nodes, nerve irritation and now possibly some tendinitis of shoulder, possibly from underuse
After initial fatigue developed  severe congestion then a bout  of vertigo which resulted in nausea and vomiting. Lasted a few hours in the middle of the night on the 6th.
Significant aphasia, difficulty speaking, finding words, thinking a word and a different word comes out. Insidious onset, with significant worsening on 10/24/23. Led to eval in ED. Began resolving while in ED. Workup for stroke was negative. No treatment. Continues to be present but mild, still quite noticeable and interferes with ability to work.
We received yesterday from the Health Department  a Moderna vial labelled in the paper work as Booster & the vial mentioned Booster Only. We thought this was the Bivalent vaccine we ordered. We had a patient coming today requesting the Booster. We administered 0.5 ml of the Booster vial. Patient tolerated the vaccine with no complications. However when we started documenting the vaccine we realized that the Booster labelled Moderna vaccine had the same Lot # as the Pediatric Moderna 6-11 years. Then we went to the guidelines & realized that the Moderna Bivalent should have a Gray border & the wording Bivalent on it.  We contacted Moderna representative & she mentioned currently Moderna does not repeat the dose in such cases of accidental administration of  Primary series vaccine for a Booster dose.
On Dec 2, 2021 I experienced sudden onset of cough and sore throat. I reported this to my supervisor who instructed me to get a covid test and then go home awaiting results. I did a self-administered nasal test at the hospital where I work. Later that evening I felt worse and had fever, nasal congestion, achiness, earache and headache along with the sore throat and cough. By Dec 4 my fever was over 102 and I felt extremely tired. My Covid test came back negative so I did another home test on Dec 4 which I feel may not have been done correctly since I felt so sick and did the test lying down. Those results were also negative. I had a doctor's office visit with the nurse practitioner at my PCP office on Dec 6. She instructed me to stay home from work the rest of the week. I continued to feel sick the entire week and on Dec 9 I lost my sense of smell. I did another home Covid test the next day and it was negative. By Dec 13 I felt well enough to return to work but not completely recovered. I had evening low-grade fevers through Dec 15.  My sense of smell returned Dec 17. My cough continued until Dec 31. I saw my doctor for my annual physical on Dec 22 and she thought I may have had a flu virus or even a missed Covid  diagnosis due to the early first Covid test and the probable incorrect self-testing. I completely recovered on Dec 31. I do not feel my illness had anything to do with my vaccine.  In fact I feel that if I did contract Covid,  the vaccine protected me from hospitalization. There was also a flu virus in our community at the time .
Patient presenting to the emergency department as a code stroke for weakness. Last known well was 1 pm today per EMS. Patient had arm weakness, slurred speech, and was unable to stand.
Rash Pruritic Information has been received from a health professional concerning a 29 month old white male with no allergies or medical conditions who on 01-JUN2004 was vaccinated SC with a first dose of varicella virus vaccine live (Oka/Merck) (Lot #647761/0097P). Concomitant therapy included a first dose SC of measles mumps rubella vaccine (MSD) (lot #646906/0956N). There was no illness at the time of vaccination. On 27-OCT-2005 the patient came to the office with an itchy rash that started at 13:00. It was reported that it started on the nape of the neck, abdomen, bilateral legs, face and tongue. There were approximately 50 lesions. No labs or diagnostic studies were done. Subsequently, the patient recovered from itchy rash the same day. Additional information is not expected.
VACCINE SAT AT 1:30 PM, SUNDAY 9:00 AM FEELING TIRED NAUSEATED, TEMP UP TO101 THROUGH THE DAY, HEADACHE,PAIN IN LEFT ARM AT INJECTION SITE. TEMP SEEMED TO BREAK THAT EVENING 98.0 . MONDAY INJECTION SITE VERY RED AND RAISED, ITCHY, ABOUT 1 TO 1 1/2 INCHES IN SIZE. TODAY TUESDAY SAME SIZE ITCHY NOT RAISED .
This spontaneous case, initially received from other health professional (nurse) on 04-Dec-2017, concerning a 42-year-old adult male patient. The patient had no medical history and he did not receive any concomitant medications. On 01-Dec-2017, the patient was administered with AFLURIA (dose: 0.5 ml, route of administration; intramuscular, anatomical location: deltoid, batch number: XT30006 and expiry date: 07-Jun-2018), which underwent temperature excursion of maximum 55 degree Fahrenheit for 3.5 hours (explicitly coded as incorrect product storage and drug administration error). It was reported that, no adverse event was noted. The reporter assessed the events as non-serious. Non-significant follow up received on 03-Jan-2018: The reporter confirmed the age (42-year-old) of the patient and batch number (XT30006) of the vaccine.
Immediate soreness at injection site. Patient developed swelling and warmth within four days of receiving vaccination.
Pt recvd Recomb w/o adverse exp; pt recvd 2nd dose & 2 day p/vax devel throbbing h/a & blood pressure was noted to be 190/110; P/3 wks of experiencing sx pts h/a subsided & BP returned to 114/72; pt took advil;
He had to miss his scheduled 2nd shot which was in Mid March; Covid infection contracted after 1st shot; This spontaneous case was reported by a patient and describes the occurrence of OFF LABEL USE (He had to miss his scheduled 2nd shot which was in Mid March) and COVID-19 (Covid infection contracted after 1st shot) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced COVID-19 (Covid infection contracted after 1st shot). On an unknown date, the patient experienced OFF LABEL USE (He had to miss his scheduled 2nd shot which was in Mid March). At the time of the report, OFF LABEL USE (He had to miss his scheduled 2nd shot which was in Mid March) had resolved and COVID-19 (Covid infection contracted after 1st shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  No treatment details were provided   This case was linked to MOD-2021-127936 (Patient Link).
At 12:15pm client showed signs of passing out. He was lowered to floor and feet elevated. 12:20 pm  v/s within normal limits O2 was 96%. 911 called. Ammonia inhalants x 1 used. client awake very drowsy but able to say his name and aware of location and able to recognize his brother. Ambulance arrived at 12:40. Client assessed by EMT and able to sit up. Child and family take to ambulance for further  assessment.
Information has been received from a licensed practical nurse concerning a female (age not reported) who on 25-OCT-2007 was vaccinated subcutaneously with  0.5 mL dose of PNEUMOVAX 23. On an unspecified date, the patient developed redness, warmth and swelling in the arm which she was vaccinated. The symptoms spread down to her elbow (the elbow was swollen as well). The nurse was unsure if this was the first dose or a booster dose of PNEUMOVAX 23. The patient sought unspecified medical attention as was "told to treat area with an ice pack and BENADRYL 25 mg every 6 hours. The patient's status was not reported. There was no product quality complaint. Following information obtained on 23-JAN-2008. It was reported that on 25-OCT-2007, the 79 year old female patient weighing 79 pounds with a history of hypertension and elevated cholesterol was vaccinated subcutaneously in the right arm with the first dose of PNEUMOVAX 23. On 26-OCT-2007, the patient complaint of her arm being red, warm and swollen down to her right elbow. The patient was treated with BENADRYL oral, 25 mg six times a day and to apply ice to injection site. On an unspecified date the patient recovered. It was also reported that that patient had back/hip pain at time of vaccination. Additional information has been requested.
Delayed localized allergic reaction; Real itchy; A spot on the arm which was the size of a "lid on the can of vegetables; Red; Rash; This spontaneous case was reported by a patient and describes the occurrence of HYPERSENSITIVITY (Delayed localized allergic reaction), PRURITUS (Real itchy), RASH MACULAR (A spot on the arm which was the size of a "lid on the can of vegetables), ERYTHEMA (Red) and RASH (Rash) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Rash). On 13-Feb-2021, the patient experienced HYPERSENSITIVITY (Delayed localized allergic reaction), PRURITUS (Real itchy), RASH MACULAR (A spot on the arm which was the size of a "lid on the can of vegetables) and ERYTHEMA (Red). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, HYPERSENSITIVITY (Delayed localized allergic reaction) and PRURITUS (Real itchy) outcome was unknown and RASH MACULAR (A spot on the arm which was the size of a "lid on the can of vegetables), ERYTHEMA (Red) and RASH (Rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   The patient was also prescribed a topical cream, however, she did not use it as her rash went away.
lt arm swelling, erythema, & tenderness from shoulder to 2" above elbow; began approx 2 hrs p/vax; treated w/ice & advil;
Pt recvd Engerix-B given 25JUL90, 24AUG90, 4FEB91; There was non-response to the 3 dose series of Engerix-B vax; tx plan to administer 2 addtl doses of vax;P/ 2 add'l vaxs metastic bone disease was DX.
Sore arm, chills, slight fever, aches, stiff neck, diarrhea x 3 days.
pt recv vax & exp h/a & nausea;pt was seen by MD dx a streptococcal infect & prescribed an antibiotic & APAP #3;began to improve p/1wk;
Itching and redness on bilateral deltoid area. More on Left arm. Employee came to me around 9:00AM and she had lacerations on left deltoid where she had scratched. Advised to take Zyrtec, apply ice, and 1% Hydrocortisone cream on both arms. Employee continued w/daily work. Checked with employee about 4 hours later and she stated itching resolved.
Red rash; Fever; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash ), PYREXIA (Fever ), HEADACHE (Headache) and FATIGUE (Fatigue) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 017B21A) for COVID-19 vaccination.     The patient's past medical history included Fatigue, Acid reflux (oesophageal), Insomnia and Restless legs. Previously administered products included for Product used for unknown indication: pneumococcal vaccine. Past adverse reactions to the above products included No adverse event with pneumococcal vaccine. Concurrent medical conditions included Osteoporosis. Concomitant products included CALCIUM for Osteoporosis, RISEDRONATE SODIUM (ACTONEL), CLONAZEPAM, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), ROPINIROLE, ASPIRIN [ACETYLSALICYLIC ACID], FISH OIL, MULTIVITAMINS [VITAMINS NOS], VITAMIN C [ASCORBIC ACID] and VITAMIN E NOS for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 27-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash ), PYREXIA (Fever ), HEADACHE (Headache) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 28-Feb-2021, PYREXIA (Fever ) and HEADACHE (Headache) had resolved. On 01-Mar-2021, RASH ERYTHEMATOUS (Red rash ) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (Inconclusive) 101.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: The additional information document received on 20-MAY-2021.Medical history information was added. Concomitant drugs were added. Second dose details were added.
2/24 - Left arm very sore  by 6:00 PM, took 500MG Tylenol.  2/25 - Arm still very sore,  temp up 1 point above my normal, feeling very tired and achy,  took 500  MG Tylenol at 12:30.  Felt unwell all day.  Took 650 MG Tylenol at 5:00PM and 11:00 PM.  2/26 - Arm is  still moderately sore , but otherwise feeling better.  2/27 - Arm is still somewhat sore.  With the 1st dose on 2/3, my  arm was sore for 24 hours and I had no other symptoms.
Returned to office with abdominal pain - Rt leg numbness and Rt back pain - resolved after resting 40 min.
Received flu vaccine at 4:00p.m. on 10-11-10. By midnight I was vomiting & had bloated abdomen followed by severe diarrhea - vomiting & severe diarrhea for 7 days - called internist - he ordered anti-nausea med - Prochlorper 10 mg. every 6 hours with IMODIUM for the diarrhea - I didn't eat for 1 week - sickest I have ever been. Still not completely recovered after 7 days.